semaglutide obesity phase 3 In the OASIS 4 trial, once-daily oral at a dose of 25 mg resulted in a greater mean reduction in body weight than placebo in participants with overweight or Two-year effects of semaglutide in

Both medications have FDA-approved uses, though approval specifics vary depending on the product and intended use

Patients with pernicious anemia This autoimmune condition destroys intrinsic factor, the protein required for B12 absorption in the small intestine

This side effect is generally transient but should be monitored if: You experience palpitations Theres a noticeable, sustained increase over time Its advisable to have regular cardiac assessments while on GLP-1 medication, especially if you have underlying heart conditions

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6)

If you want a deeper look at the prescribing process, how to get prescribed semaglutide for weight loss walks through the next steps